Loading clinical trials...
Loading clinical trials...
A Phase 1 Safety and Tolerability Study of Infused Donor T Regulatory Cells in Steroid Dependent/Refractory Chronic Graft Versus Host Disease
Conditions
Interventions
Regulatory T Cells
Locations
1
United States
Stanford University, School of Medicine
Palo Alto, California, United States
Start Date
July 1, 2013
Primary Completion Date
December 31, 2017
Completion Date
July 31, 2018
Last Updated
September 27, 2021
NCT06705062
NCT01804686
NCT07356245
NCT04745221
NCT04660487
NCT06271616
Lead Sponsor
Laura Johnston
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions